Literature DB >> 28240208

[Autoimmune disease predisposition: Aire « protects » men].

Nadine Dragin1, Rozen Le Panse1, Sonia Berrih-Aknin1.   

Abstract

Autoimmune diseases are a group of about 80 different diseases affecting 5-8% of the population. They are due to a deregulation of the immune system that attacks specific molecules and/or cells in the body. The thymus is the school of T cells that must be able to react to foreign molecules penetrating into the body. This education process is mediated by interactions between T cells and thymic epithelial cells (TEC) that express specific proteins of the peripheral tissues (TSA, "tissue-specific antigen"). This complex mechanism is called central tolerance. Most of the autoimmune diseases display a common feature : women are more susceptible to these diseases than men. Since the thymus is the main organ of central tolerance, we conducted a comparative study of thymic transcriptome of women and men. Our data revealed sex-associated differences in the expression of TSAs that are controlled by the autoimmune regulator (AIRE), a key factor in central tolerance. By studying human and murine cell models, we analyzed the relationship between gender, hormones and AIRE. Our work shows that AIRE is less expressed in women than in men after puberty. Furthermore, we show that estrogen induces decreased thymic AIRE expression by epigenetic modifications through increased number of methylation sites within the AIRE promoter. Consequently, these data suggest that from puberty, women have a reduced effectiveness of central tolerance process, leading to increased number of autoreactive lymphocytes, and as a result, increased susceptibility to autoimmune diseases. Together, these data may question the impact of exposure to "estrogen-like" molecules on the growing incidence of autoimmune diseases.
© 2017 médecine/sciences – Inserm.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28240208     DOI: 10.1051/medsci/20173302012

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  3 in total

1.  Hypermethylation of MDFI promoter with NSCLC is specific for females, non-smokers and people younger than 65.

Authors:  Hongying Ma; Xiaoying Chen; Haochang Hu; Bin Li; Xiuru Ying; Cong Zhou; Jie Zhong; Guofang Zhao; Shiwei Duan
Journal:  Oncol Lett       Date:  2018-04-18       Impact factor: 2.967

2.  Real-world questions and concerns about disease-modifying antirheumatic drugs (DMARDs): a retrospective analysis of questions to a medicine call center.

Authors:  Hiba El Masri; Samantha A Hollingworth; Mieke van Driel; Helen Benham; Treasure M McGuire
Journal:  BMC Rheumatol       Date:  2020-06-16

3.  Prognostic value of B cells in cutaneous melanoma.

Authors:  Sara R Selitsky; Lisle E Mose; Christof C Smith; Shengjie Chai; Katherine A Hoadley; Dirk P Dittmer; Stergios J Moschos; Joel S Parker; Benjamin G Vincent
Journal:  Genome Med       Date:  2019-05-28       Impact factor: 11.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.